Low-dose doxepin formulations and methods of making and using the same
US9532971B2 · kind B2 · utility
1Cited by
48References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 20, 2013 |
| Grant date | Jan 3, 2017 |
| Priority date | — |
| Expiry date | Jul 10, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/20
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention disclosed herein generally relates to low-dose oral doxepin pharmaceutical formulations and the use of these formulations to promote sleep.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.